KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Common Equity (2016 - 2025)

Humana has reported Common Equity over the past 17 years, most recently at $17.7 billion for Q4 2025.

  • Quarterly results put Common Equity at $17.7 billion for Q4 2025, up 7.86% from a year ago — trailing twelve months through Dec 2025 was $17.7 billion (up 7.86% YoY), and the annual figure for FY2025 was $17.7 billion, up 7.86%.
  • Common Equity for Q4 2025 was $17.7 billion at Humana, down from $18.6 billion in the prior quarter.
  • Over the last five years, Common Equity for HUM hit a ceiling of $18.6 billion in Q3 2025 and a floor of $14.2 billion in Q1 2021.
  • Median Common Equity over the past 5 years was $16.4 billion (2023), compared with a mean of $16.5 billion.
  • Biggest five-year swings in Common Equity: increased 17.3% in 2021 and later decreased 4.55% in 2022.
  • Humana's Common Equity stood at $16.1 billion in 2021, then decreased by 4.55% to $15.4 billion in 2022, then grew by 6.17% to $16.3 billion in 2023, then increased by 0.78% to $16.4 billion in 2024, then rose by 7.86% to $17.7 billion in 2025.
  • The last three reported values for Common Equity were $17.7 billion (Q4 2025), $18.6 billion (Q3 2025), and $18.3 billion (Q2 2025) per Business Quant data.